InvestorsHub Logo
Post# of 252585
Next 10
Followers 122
Posts 8884
Boards Moderated 0
Alias Born 10/05/2004

Re: None

Friday, 02/11/2011 9:25:06 AM

Friday, February 11, 2011 9:25:06 AM

Post# of 252585
Bought DSCI at $10 and it's been doing very well. Market cap is tiny. Undervalued imo based on the potential. Just had good phase 2 results for their diabetic foot ulcers. phase 3 trials are estimated to cost about $15 million. with just a little dilution, they could fund them themselves and not have to give a way a piece of the pie to a partner. they are already generating revenues of around $40 million that is growing.

http://www.ustream.tv/recorded/7994431 - this link is a good one.

http://www.dermasciences.com

http://finance.yahoo.com/news/Derma-Sciences-Reports-bw-3870462175.html?x=0&.v=1

http://www.thestreet.com/_yahoo/story/10995888/1/biotech-stock-mailbag-derma-sciences.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA

http://www.americanbankingnews.com/2011/02/09/analysts-price-target-changes-for-february-9th-cxo-dis-dsci-emc-fis-flo/

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.